Mary O’Kane

ORCID: 0000-0002-5216-6024
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bariatric Surgery and Outcomes
  • Diet and metabolism studies
  • Obesity and Health Practices
  • Body Contouring and Surgery
  • Higher Education Governance and Development
  • Nutrition and Health in Aging
  • Pharmacology and Obesity Treatment
  • Cardiac, Anesthesia and Surgical Outcomes
  • Higher Education Practises and Engagement
  • Obesity, Physical Activity, Diet
  • Delphi Technique in Research
  • Transplantation: Methods and Outcomes
  • Fatty Acid Research and Health
  • Psychological Well-being and Life Satisfaction
  • Disaster Response and Management
  • COVID-19 and Mental Health
  • Gastric Cancer Management and Outcomes
  • Diet, Metabolism, and Disease
  • Nutritional Studies and Diet
  • Enhanced Recovery After Surgery
  • Legal Language and Interpretation
  • COVID-19 and healthcare impacts
  • Esophageal and GI Pathology
  • Neonatal skin health care
  • Obstructive Sleep Apnea Research

Leeds Teaching Hospitals NHS Trust
2010-2024

St James's University Hospital
2010-2024

King's College Hospital
2022

Public Health England
2021

Leeds General Infirmary
1988-2020

The University of Adelaide
1996

MAJOR UPDATES TO 1991 NATIONAL INSTITUTES OF HEALTH GUIDELINES FOR BARIATRIC SURGERY: Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) >35 kg/m2, regardless of presence, absence, or severity co-morbidities.MBS should be considered metabolic disease BMI 30-34.9 kg/m2.BMI thresholds adjusted in the Asian population such that >25 kg/m2 suggests clinical obesity, >27.5 offered MBS.Long-term results MBS consistently demonstrate safety...

10.1007/s11695-022-06332-1 article EN cc-by Obesity Surgery 2022-11-07

Summary Bariatric surgery can facilitate weight loss and improvement in medical comorbidities. It has a profound impact on nutrition, patients need access to follow‐up aftercare. NICE CG189 Obesity emphasized the importance of minimum 2 years bariatric surgical service recommended that following discharge from service, there should be annual monitoring as part shared care model chronic disease management. NHS England Clinical Reference Group commissioned multi‐professional subgroup, which...

10.1111/cob.12145 article EN Clinical Obesity 2016-05-10

Coronavirus disease 2019 (COVID-19) has led to unprecedented changes in the way we live, particularly for people at higher risk of severe illness from COVID-19. People with pre-existing health conditions have been markedly impacted and, some instances, left unsupported due reduced provision routine healthcare services. living obesity (PLWO) are identified as COVID-19 infection. Currently, there is a paucity evidence about impact first lockdown on PLWO, including those accessing weight...

10.1016/j.eclinm.2021.100796 article EN cc-by-nc-nd EClinicalMedicine 2021-03-20

Abstract Metabolic and bariatric surgery (MBS) is widely considered the most effective option for treating obesity, a chronic, relapsing, progressive disease. Recently, American Society of Bariatric Surgery (ASMBS) International Federation Obesity Disorders (IFSO) issued new guidelines on indications MBS, which have superseded previous 1991 National Institutes Health guidelines. The aim this study to establish first set consensus selecting procedures in Class I II using an Expert Modified...

10.1038/s41598-024-54141-6 article EN cc-by Scientific Reports 2024-02-11

In a 12‐month randomly allocated double‐blind trial in 19 obese Type 2 diabetic patients, fluoxetine 60 mg daily compared to placebo produced significant fall median body weight after 3 months (3.8 kg), 6 (6.5 9 (7.1 and at 1 year (5.8 kg). Median fasting blood glucose HbA 1c levels fell significantly (1.9 mmol l −1 1.7 %, respectively) (1.8 1.7%) but neither showed difference or 12 therapy with fluoxetine. There were no changes serum cholesterol the patients on triglyceride level (0.5 not...

10.1111/j.1464-5491.1994.tb00238.x article EN Diabetic Medicine 1994-01-02

Obesity surgery is an appropriate treatment option for patients with severe and complex obesity helps in the improvement of comorbidities. In first 2 years following surgery, follow-up provided by centre. Ongoing care then usually returned to general practitioner. Patients need access ongoing support monitoring otherwise may be at risk developing nutritional deficiencies such as anaemia or protein malnutrition. The British Metabolic Surgery Society have developed guidelines on supplements...

10.1111/cen.13041 article EN Clinical Endocrinology 2016-02-20

The COVID-19 pandemic has negatively impacted people living with obesity. aim was to examine the continued impact of on mental health obesity and associations food insecurity, loneliness health-related behaviours.The study recruited 1187 UK adults who completed an online survey, which examined behaviours from July 2020 (end first lockdown in United Kingdom) point they survey 2021. Regression analyses were used relationships between outcome variables demographic factors, hierarchical linear...

10.1111/jhn.13120 article EN cc-by-nc-nd Journal of Human Nutrition and Dietetics 2022-11-26
Coming Soon ...